Early Phase Clinical Trials: Canada – LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline:
External Deadline: Open Call
Description
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs of managing these diseases will rise significantly within a generation. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data.
NEW for 2019:
Weston Brain Institute is expanding the scope of the program to include clinical trial projects investigating complementary approaches (e.g., diet, physical activity, sleep, nutritional supplements, speech therapy, cognitive therapy, music therapy, social interaction), if these applications meet our other scope criteria and have supportive evidence/justification (from published literature or unpublished data) to warrant further investigation.
- The Early Phase Clinical Trials: Canada program will now be run on a rolling basis. Applicants may submit an LOI at any time and will be notified of whether to prepare a full Proposal within ~2 months of LOI submission.
- See our participant recruiting suggestions for ways of strengthening your recruiting plan in your proposal, and making recruiting faster and easier.
Please refer to the Program Details and Request for Applications (RFA) documents for more information.
Additional Information can be found at the Weston Brain Institute webpage.